Travere Therapeutics Ownership | Who Owns Travere Therapeutics?
Travere Therapeutics Ownership Summary
Travere Therapeutics is owned by 45.09% institutional investors, 0.65% insiders, and 54.26% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.31% of TVTX shares. Delaware Small Cap Core I is the top mutual fund, with 4.42% of its assets in Travere Therapeutics shares.
TVTX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Travere Therapeutics | 45.09% | 0.65% | 54.26% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock funding, inc. /de | 8.02M | 10.31% | $139.68M |
Blackrock | 7.64M | 9.86% | $62.84M |
Armistice capital | 7.36M | 9.46% | $128.18M |
Vanguard group | 6.74M | 8.67% | $117.45M |
Rock springs capital management lp | 4.97M | 6.39% | $86.64M |
Macquarie group | 4.26M | 5.48% | $74.20M |
Janus henderson group | 4.06M | 5.22% | $70.69M |
State street | 3.51M | 4.53% | $28.86M |
Morgan stanley | 3.49M | 4.50% | $28.69M |
Viking global investors lp | 2.90M | 3.73% | $50.55M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Rock springs capital management lp | 4.97M | 3.30% | $86.64M |
Parkman healthcare partners | 1.12M | 2.59% | $19.47M |
Birchview capital, lp | 148.00K | 2.10% | $2.58M |
Logos global management lp | 1.00M | 2.04% | $17.42M |
Kynam capital management, lp | 1.80M | 1.86% | $31.40M |
Armistice capital | 7.36M | 1.75% | $128.18M |
Knott david m jr | 228.00K | 1.44% | $3.97M |
Emerald advisers | 2.13M | 1.43% | $37.03M |
Emerald mutual fund advisers trust | 1.10M | 1.17% | $19.19M |
Silverarc capital management | 277.37K | 1.06% | $4.83M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Janus henderson group | 4.06M | 0.04% | 4.03M |
Viking global investors lp | 2.90M | 0.16% | 2.90M |
Bnp paribas arbitrage, snc | 1.21M | 0.01% | 1.21M |
Ra capital management | 1.15M | 0.27% | 1.15M |
Fmr | 1.12M | 0.00% | 972.60K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
State street | 3.51M | 0.00% | -3.10M |
Woodline partners lp | 2.11M | 0.25% | -2.23M |
Finepoint capital lp | - | - | -1.78M |
Balyasny asset management | - | - | -1.29M |
Assenagon asset management | 530.51K | 0.01% | -844.01K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Viking global investors lp | 2.90M | 0.16% | 2.90M | $50.55M |
Bnp paribas arbitrage, snc | 1.21M | 0.01% | 1.21M | $21.07M |
Ra capital management | 1.15M | 0.27% | 1.15M | $20.03M |
Jennison associates | 816.40K | 0.01% | 816.40K | $14.22M |
Abrdn | 392.00K | 0.01% | 392.00K | $6.83M |
Sold Out
Holder | Change |
---|---|
Toronto dominion bank | -3.00 |
Nelson, van denburg & campbell wealth management group | -14.00 |
Global retirement partners | -19.00 |
Innealta capital | -28.00 |
Northwestern mutual wealth management | -39.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 107 | -42.47% | 35,070,340 | -57.58% | 45 | 0.40% | 66 | -30.53% | 23 | -58.93% |
Sep 30, 2024 | 185 | 5.11% | 82,651,760 | -6.09% | 106 | 0.82% | 96 | -6.80% | 54 | 14.89% |
Jun 30, 2024 | 176 | -1.68% | 88,008,878 | 0.38% | 113 | 0.88% | 103 | 10.75% | 47 | -7.84% |
Mar 31, 2024 | 179 | 2.29% | 87,677,449 | 2.46% | 113 | 0.91% | 93 | 3.33% | 51 | -5.56% |
Dec 31, 2023 | 175 | -7.41% | 85,573,713 | 3.91% | 111 | 0.96% | 90 | -15.09% | 54 | 8.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Delaware Small Cap Core I | 3.45M | 4.42% | -21.39K |
Macquarie Small Cap Core I | 3.45M | 3.89% | - |
Vanguard Total Stock Mkt Idx Inv | 2.74M | 3.09% | 28.34K |
Aviva Investors GlConvtAbsRet I USD Acc | 2.20M | 2.88% | -229.35K |
Vanguard US Total Market Shares ETF | 2.51M | 2.82% | - |
iShares Russell 2000 ETF | 2.22M | 2.50% | -19.25K |
SPDR® S&P Biotech ETF | 1.78M | 2.00% | -19.04K |
HBM Healthcare Investments AG Ord | 1.63M | 1.87% | 127.15K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.20M | 1.35% | 1.77K |
Vanguard Strategic Equity Inv | 842.88K | 0.97% | -129.29K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Apr 11, 2025 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sell | $630.94 |
Feb 12, 2025 | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | Sell | $122.36K |
Feb 12, 2025 | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | Sell | $188.24K |
Feb 11, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Sell | $375.00K |
Feb 11, 2025 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Sell | $231.10K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 26 |
2024 Q4 | - | 4 |
2024 Q3 | - | 9 |
2024 Q2 | - | 1 |
2024 Q1 | - | 18 |
TVTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools